The effect of hysterectomy on survival of patients with borderline ovarian tumors

被引:24
|
作者
Menczer, Joseph [1 ,2 ]
Chetrit, Angela [3 ]
Sadetzki, Siegal [2 ,3 ]
机构
[1] E Wolfson Med Ctr, Gynecol Oncol Unit, Dept Obstet & Gynecol, Holon, Israel
[2] Tel Aviv Univ, Fac Med, IL-69978 Tel Aviv, Israel
[3] Sheba Med Ctr, Canc & Radiat Epidemiol Unit, Gertner Inst Epidemiol & Hlth Policy, Tel Hashomer, Israel
关键词
Borderline ovarian tumors; Uterine involvement; Effect of hysterectomy on survival; IN-VITRO FERTILIZATION; CANCER; NEOPLASMS; SURGERY; IMPACT; WOMEN;
D O I
10.1016/j.ygyno.2012.02.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The classically recommended surgical treatment of borderline ovarian tumors (BOTs) includes hysterectomy in addition to bilateral adnexectomy. Possible reasons for hysterectomy might be a high frequency of uterine involvement and its favorable effect on survival. The purpose of the present study was to assess the frequency of uterine involvement in patients with BOTs and the effect of hysterectomy on survival. Methods. All incident cases of histological confirmed BOTs diagnosed in Israeli Jewish women between March 1 1994 and June 30 1999, were identified. Clinical and pathological characteristics were abstracted from medical records. Patients with tumors grossly confined to the ovaries (apparently stage I) were considered to have had surgical staging when at least hysterectomy, bilateral salpingooophorectomy, omentectomy and pelvic lymph node sampling were done. Results. The study group comprised 225 patients. Hysterectomy was performed in 147 (65.31%) patients and uterine involvement was present in only 3 (2.0%) of them. The 13 year survival of the total group of patients was 85.8% and of those in apparent stage 1,88.5%. Among patients with tumors apparently confined to the ovaries, no significant survival difference was observed between unstaged and surgically staged patients. There was also no survival difference between the overall staged and unstaged patients and between patients in stages II-III who did and did not undergo hysterectomy. Conclusions. Our data indicate that the rate of uterine involvement in HOT is low and that hysterectomy does not favorably affect survival. The necessity of hysterectomy in BOT patients is questioned. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:372 / 375
页数:4
相关论文
共 50 条
  • [1] Is there a justification for hysterectomy in patients with borderline ovarian tumors?
    Ouldamer, L.
    Lacoste, C.
    Cormier, B.
    Arbion, F.
    Marret, H.
    Jallais, L.
    Fignon, A.
    Body, G.
    [J]. SURGICAL ONCOLOGY-OXFORD, 2016, 25 (01): : 1 - 5
  • [2] Develop a nomogram to predict overall survival of patients with borderline ovarian tumors
    Gong, Xiao-Qin
    Zhang, Yan
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (07) : 2115 - 2126
  • [3] Develop a nomogram to predict overall survival of patients with borderline ovarian tumors
    Xiao-Qin Gong
    Yan Zhang
    [J]. World Journal of Clinical Cases, 2022, (07) : 2115 - 2126
  • [4] The impact of hysterectomy on oncological outcomes in postmenopausal patients with borderline ovarian tumors: A multicenter retrospective study
    Raimondo, Diego
    Raffone, Antonio
    Scambia, Giovanni
    Maletta, Manuela
    Lenzi, Jacopo
    Restaino, Stefano
    Mascilini, Floriana
    Trozzi, Rita
    Mauro, Jessica
    Travaglino, Antonio
    Driul, Lorenza
    Casadio, Paolo
    Mollo, Antonio
    Fagotti, Anna
    Vizzielli, Giuseppe
    Seracchioli, Renato
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] The Value of Random Biopsies, Omentectomy, and Hysterectomy in Operations for Borderline Ovarian Tumors
    Kristensen, Gitte Schultz
    Schledermann, Doris
    Mogensen, Ole
    Jochumsen, Kirsten Marie
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (05) : 874 - 879
  • [6] The impact of hysterectomy on oncological outcomes in patients with borderline ovarian tumors: A systematic review and meta-analysis
    Raimondo, Diego
    Raffone, Antonio
    Zakhari, Andrew
    Maletta, Manuela
    Vizzielli, Giuseppe
    Restaino, Stefano
    Travaglino, Antonio
    Krishnamurthy, Srinivasan
    Mabrouk, Mohamed
    Casadio, Paolo
    Mollo, Antonio
    Scambia, Giovanni
    Seracchioli, Renato
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 165 (01) : 184 - 191
  • [7] Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors
    Matsuo, Koji
    Machida, Hiroko
    Takiuchi, Tsuyoshi
    Grubbs, Brendan H.
    Roman, Lynda D.
    Sood, Anil K.
    Gershenson, David M.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 144 (03) : 496 - 502
  • [8] BORDERLINE OVARIAN TUMORS: A NATIONWIDE OVERVIEW OF INCIDENCE, SURVIVAL AND RISK OF SUBSEQUENT INVASIVE OVARIAN TUMORS
    Schuurman, M.
    Timmermans, M.
    van de Vijver, K.
    van Gorp, T.
    Kruitwagen, R.
    van der Aa, M.
    Lemmens, V.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 91 - 91
  • [9] BORDERLINE OVARIAN TUMORS: A NATIONWIDE OVERVIEW OF INCIDENCE, SURVIVAL AND RISK OF SUBSEQUENT INVASIVE OVARIAN TUMORS
    Schuurman, M.
    Timmermans, M.
    van de Vijver, K.
    van Gorp, T.
    Kruitwagen, R.
    van der Aa, M.
    Lemmens, V.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 547 - 547
  • [10] Fertility preservation in patients with borderline ovarian tumors
    Kreuzer V.K.
    Fehm T.N.
    [J]. Der Gynäkologe, 2018, 51 (11): : 946 - 950